Henlius Speeds Up Efforts On Ophthalmic Bevacizumab

Phase III Trial Begins As Chinese Firm Works With Partner Essex On Global Filings

Eye Data Ophthalmic
Henlius is eyeing several marketing authorization applications • Source: Sergey Nivens

More from Biosimilars

More from Products